{
  "image_filename": "figure_p3_det_2_002.png",
  "image_path": "Zimmerman_et_al.__2023_/extracted/figures/figure_p3_det_2_002.png",
  "image_type": "Figure",
  "page_number": 3,
  "block_id": "det_2_002",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "A flowchart depicting the study cohort selection: initial cohort (N=18,467), applied exclusion criteria to yield an analyzable cohort (N=14,590), then split into Controls (N=12,837) and Influenza cases (N=1,803), each further subdivided by vaccination status (RIV4, SD-IIV4, Unvaccinated) with respective counts. does not support the claim because the figure only presents participant flow and vaccine group counts without any information on antigenic matching to WHO- or FDA-selected strains",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A flowchart depicting the study cohort selection: initial cohort (N=18,467), applied exclusion criteria to yield an analyzable cohort (N=14,590), then split into Controls (N=12,837) and Influenza cases (N=1,803), each further subdivided by vaccination status (RIV4, SD-IIV4, Unvaccinated) with respective counts.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the figure only presents participant flow and vaccine group counts without any information on antigenic matching to WHO- or FDA-selected strains",
    "confidence_notes": null
  }
}